Literature DB >> 25344889

Implications in dosimetry of the implementation of the revised dose limit to the lens of the eye.

J Broughton1, M C Cantone2, M Ginjaume3, B Shah1, R Czarwinski4.   

Abstract

In 2012, International Radiation Protection Association (IRPA) established a Task Group to provide an assessment of the impact of the implementation of the ICRP-revised dose limit for the lens of the eye for occupational exposure. Associated Societies (ASs) of IRPA were asked to provide views and comments on the basis of a questionnaire addressing three principal topics: (i) implications for dosimetry, (ii) implications for methods of protection and (iii) wider implications of implementing the revised limits. A summary of the collated responses regarding dosimetry is presented and discussed. There is large agreement on the most critical aspects and difficulties in setting up an appropriate monitoring programme for the lens of the eyes. The recent international standards and technical documents provide guidance for some of the concerns but other challenges remain in terms of awareness, acceptance and practicalities.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Mesh:

Year:  2014        PMID: 25344889     DOI: 10.1093/rpd/ncu320

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Monitoring neurointerventional radiation doses using dose-tracking software: implications for the establishment of local diagnostic reference levels.

Authors:  Holly Acton; Karl James; Richard G Kavanagh; Colm O'Tuathaigh; Deirdre Moloney; Gerald Wyse; Noel Fanning; Michael Maher; Owen J O'Connor
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

2.  On the scenario of passive dosimeters in personnel monitoring: Relevance to diagnostic radiology and fluoroscopy-based interventional cardiology.

Authors:  A S Pradhan; J I Lee; J L Kim
Journal:  J Med Phys       Date:  2016 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.